Of children who reported a problem with using their devices, 9% asked a question about how to use their asthma medication devices. Only 4% of children who reported Z VAD FMK difficulty remembering when to take their asthma medications asked a question about the frequency or timing of using their asthma medication. Only one child asked a question about side effects when they reported a side-effect problem (n = 98). None of the 79 children who reported a problem or concern in using their asthma medications during school asked their provider questions about how to use their medications at school. Table 3 presents the GEE results predicting which caregivers

who reported one or more problems or concerns with their children’s asthma medications

would ask at least one medication-related question during the paediatric asthma medical visit. Older caregivers were significantly more likely to ask at least one medication-related question during the medical visit than younger caregivers (odds ratio (OR) = 1.04, 95% confidence interval (CI) = 1.01, 1.09). Caregivers who reported a problem or concern with their child’s asthma medications were also significantly more likely to ask medication questions if providers asked more questions about control medications during the visits (OR = 1.17, 95% OR = 1.01, 1.36). Table 4 presents the GEE results predicting whether children who reported at least check details one problem or concern with their asthma medications would have asked one or more medication questions during their paediatric asthma medical visits. Those who reported higher asthma management self-efficacy were significantly more likely to ask at least one asthma Pembrolizumab clinical trial medication question than children who reported lower self-efficacy (OR = 2.34, 95% OR = 1.26, 4.33). Children were also significantly more likely to ask one or more asthma medication questions if providers asked more control medication questions during the medical visits (OR = 1.14, 95% OR = 1.02, 1.28). Table 5 reports the percentage of children and caregivers who reported problems or concerns in using asthma medications at the initial medical visit who still reported

having medication problems 1 month later at the home visit. One month later, 67% of caregivers and 74% of children still reported having one or more asthma medication problems one month later. We found that only one in three caregivers who reported a problem with their child using an asthma medication asked a medication question during their consultations. Caregivers who reported a frequency of use/timing problem almost always asked a question about this area; yet, only about half of them asked a quantity or supply question if they reported difficulty getting refills on time. Moreover, almost two-thirds of children who reported problems at their initial consultation reported having those same problems 1 month later.